CHNR
CHNR
China Natural Resources, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $0 | $152.13K ▼ | $42.2K ▲ | 0% | $0.03 ▲ | $-152.13K ▲ |
| Q2-2025 | $0 | $3.1M ▲ | $-1.26M ▼ | 0% | $-1 ▼ | $-1.25M ▼ |
| Q4-2024 | $0 | $-1.99M ▼ | $57.84K ▲ | 0% | $-0.32 ▼ | $2.34M ▲ |
| Q2-2024 | $0 | $2M ▼ | $-61K ▲ | 0% | $-0.01 ▲ | $-2M ▲ |
| Q4-2023 | $0 | $8M | $-3.1M | 0% | $-3.71 | $-7.45M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $475.3K ▼ | $247.34M ▼ | $160.96M ▼ | $86.38M ▼ |
| Q2-2025 | $726.83K ▼ | $251.45M ▼ | $164.98M ▼ | $86.47M ▼ |
| Q4-2024 | $3.08M ▼ | $260.89M ▲ | $172.83M ▼ | $88.06M ▲ |
| Q2-2024 | $4.76M | $253.81M | $177.81M | $76M |
| Q4-2023 | $4.76M | $253.81M | $177.81M | $76M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $42.2K ▲ | $-1.6M ▲ | $49.08K ▲ | $-2.37M ▼ | $-234.15K ▲ | $-1.6M ▲ |
| Q2-2025 | $-1.26M ▲ | $-4.11M ▲ | $0 ▼ | $2.1M ▼ | $-2.3M ▼ | $-4.11M ▲ |
| Q4-2024 | $-3.16M ▼ | $-7.41M ▲ | $1K ▲ | $15.1M ▲ | $-1.67M ▲ | $-7.41M ▼ |
| Q2-2024 | $-122 ▲ | $-11.93M ▼ | $-4.03K ▼ | $7.92M ▲ | $-23.44M ▲ | $-11.85K ▼ |
| Q4-2023 | $-526.59K | $1.45M | $2.44K | $-5.13M | $-26.94M | $1.45M |
5-Year Trend Analysis
A comprehensive look at China Natural Resources, Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include a debt‑free balance sheet, ample short‑term liquidity, and a diversified set of assets across mining, prospective lithium exposure, AI hardware, and healthcare opportunities. The company’s willingness to pivot and pursue new technologies, particularly physical AI and AI‑enabled operations, shows strategic flexibility. If even part of this portfolio begins to generate sustainable revenue, CHNR could benefit from exposure to several structurally growing themes.
The main risks are severe and immediate: business revenues have effectively disappeared, operating losses and cash burn are significant, and retained earnings are heavily negative. Execution and integration risk around acquisitions is high, especially as CHNR moves into highly competitive and technically complex fields such as AI and healthcare where it lacks a long track record. Prolonged losses could eventually erode its liquidity cushion and force difficult choices around raising capital, shrinking the business, or restructuring.
The outlook is highly uncertain and depends on whether CHNR can successfully convert its strategic pivot into real, recurring revenue while tightening its cost structure. In the near term, financial performance is likely to remain weak as the company completes acquisitions and tries to ramp new products and services. Over the longer term, outcomes could range from a successful multi‑sector platform with innovative AI and healthcare offerings to continued financial strain if commercialization falls short. Monitoring progress on revenue recovery, cash burn, and concrete milestones in AI, healthcare, and mining projects will be critical to assessing how this trajectory evolves.
About China Natural Resources, Inc.
https://www.chnr.netChina Natural Resources, Inc. primarily engages in the discovery and extraction of metal deposits throughout the People's Republic of China. The company's efforts are focused on locating valuable quantities of lead, silver, and various other non-ferrous metals. A key asset is its stake in the Moruogu Tong mine, encompassing 7.81 square kilometers in Bayannaoer City, Inner Mongolia.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $0 | $152.13K ▼ | $42.2K ▲ | 0% | $0.03 ▲ | $-152.13K ▲ |
| Q2-2025 | $0 | $3.1M ▲ | $-1.26M ▼ | 0% | $-1 ▼ | $-1.25M ▼ |
| Q4-2024 | $0 | $-1.99M ▼ | $57.84K ▲ | 0% | $-0.32 ▼ | $2.34M ▲ |
| Q2-2024 | $0 | $2M ▼ | $-61K ▲ | 0% | $-0.01 ▲ | $-2M ▲ |
| Q4-2023 | $0 | $8M | $-3.1M | 0% | $-3.71 | $-7.45M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $475.3K ▼ | $247.34M ▼ | $160.96M ▼ | $86.38M ▼ |
| Q2-2025 | $726.83K ▼ | $251.45M ▼ | $164.98M ▼ | $86.47M ▼ |
| Q4-2024 | $3.08M ▼ | $260.89M ▲ | $172.83M ▼ | $88.06M ▲ |
| Q2-2024 | $4.76M | $253.81M | $177.81M | $76M |
| Q4-2023 | $4.76M | $253.81M | $177.81M | $76M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $42.2K ▲ | $-1.6M ▲ | $49.08K ▲ | $-2.37M ▼ | $-234.15K ▲ | $-1.6M ▲ |
| Q2-2025 | $-1.26M ▲ | $-4.11M ▲ | $0 ▼ | $2.1M ▼ | $-2.3M ▼ | $-4.11M ▲ |
| Q4-2024 | $-3.16M ▼ | $-7.41M ▲ | $1K ▲ | $15.1M ▲ | $-1.67M ▲ | $-7.41M ▼ |
| Q2-2024 | $-122 ▲ | $-11.93M ▼ | $-4.03K ▼ | $7.92M ▲ | $-23.44M ▲ | $-11.85K ▼ |
| Q4-2023 | $-526.59K | $1.45M | $2.44K | $-5.13M | $-26.94M | $1.45M |
5-Year Trend Analysis
A comprehensive look at China Natural Resources, Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include a debt‑free balance sheet, ample short‑term liquidity, and a diversified set of assets across mining, prospective lithium exposure, AI hardware, and healthcare opportunities. The company’s willingness to pivot and pursue new technologies, particularly physical AI and AI‑enabled operations, shows strategic flexibility. If even part of this portfolio begins to generate sustainable revenue, CHNR could benefit from exposure to several structurally growing themes.
The main risks are severe and immediate: business revenues have effectively disappeared, operating losses and cash burn are significant, and retained earnings are heavily negative. Execution and integration risk around acquisitions is high, especially as CHNR moves into highly competitive and technically complex fields such as AI and healthcare where it lacks a long track record. Prolonged losses could eventually erode its liquidity cushion and force difficult choices around raising capital, shrinking the business, or restructuring.
The outlook is highly uncertain and depends on whether CHNR can successfully convert its strategic pivot into real, recurring revenue while tightening its cost structure. In the near term, financial performance is likely to remain weak as the company completes acquisitions and tries to ramp new products and services. Over the longer term, outcomes could range from a successful multi‑sector platform with innovative AI and healthcare offerings to continued financial strain if commercialization falls short. Monitoring progress on revenue recovery, cash burn, and concrete milestones in AI, healthcare, and mining projects will be critical to assessing how this trajectory evolves.

CEO
Wah On Wong
Compensation Summary
(Year 2001)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-06-13 | Reverse | 1:8 |
| 2023-04-03 | Reverse | 1:5 |
Ratings Snapshot
Rating : C
Price Target
Institutional Ownership
Summary
Showing Top 2 of 2

